BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Shi H, Xu JM, Hu NZ, Xie HJ. Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma. World J Gastroenterol 2003; 9(7): 1421-1426 [PMID: 12854133 DOI: 10.3748/wjg.v9.i7.1421]
URL: https://www.wjgnet.com/1007-9327/full/v9/i7/1421.htm
(0) (0) (5860) (70)
Number Citing Articles
1
Ferdinando De Vita, Natale Di Martino, Alessio Fabozzi, Maria Maddalena Laterza, Jole Ventriglia, Beatrice Savastano, Angelica Petrillo, Valentina Gambardella, Vincenzo Sforza, Luigi Marano, Annamaria Auricchio, Gennaro Galizia, Fortunato Ciardiello, Michele Orditura. Clinical management of advanced gastric cancer: The role of new molecular drugs. World Journal of Gastroenterology 2014; 20(40): 14537-14558 doi: 10.3748/wjg.v20.i40.14537
2
Hai Shi, Jian Ming Xu, Nai Zhong Hu, Xue Long Wang, Qiao Mei, Yu Lin Song. Transfection of mouse macrophage metalloelastase gene into murine CT-26 colon cancer cells suppresses orthotopic tumor growth, angiogenesis and vascular endothelial growth factor expression. Cancer Letters 2006; 233(1) doi: 10.1016/j.canlet.2005.03.010
3
Deniz Yamac, Talat Ayyıldız, Uğur Coşkun, Nalan Akyürek, Ayse Dursun, Selda Seckin, Fulya Koybasioglu. Cyclooxygenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma. Pathology - Research and Practice 2008; 204(8) doi: 10.1016/j.prp.2008.01.002
4
S. Yu, G. Li, Z. Wang, Z. Wang, C. Chen, S. Cai, Y. He. The prognostic value of pSTAT3 in gastric cancer: a meta-analysis. Journal of Cancer Research and Clinical Oncology 2016; 142(3) doi: 10.1007/s00432-015-2023-1
5
Imen Miladi-Abdennadher, Rania Abdelmaksoud-Dammak, Dorra Ben Ayed-Guerfali, Lobna Ayadi, Abdelmajid Khabir, Ali Amouri, Foued Frikha, Nabil Tahri, Sameh Ellouz, Mounir Frikha, Tahia Sellami-Boudawara, Raja Mokdad-Gargouri. Expression of COX-2 and E-cadherin in Tunisian patients with colorectal adenocarcinoma. Acta Histochemica 2012; 114(6) doi: 10.1016/j.acthis.2011.11.002
6
Jing Chen, Tao Li, Yuanyuan Wu, Lijun He, Li Zhang, Tieliu Shi, Zhengfang Yi, Mingyao Liu, Xiufeng Pang. Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis. Journal of Cancer Research and Clinical Oncology 2011; 137(12) doi: 10.1007/s00432-011-1057-2
7
J. Stuart Salmon, A. Craig Lockhart, Jordan Berlin. Anti-Angiogenic Treatment of Gastrointestinal Malignancies. Cancer Investigation 2005; 23(8) doi: 10.1080/07357900500360024
8
Salem Kim, Afsaneh Barzi, Lakshmi Rajdev. Biomarker-driven targeted therapies for gastric/gastro-esophageal junction malignancies. Seminars in Oncology 2018; 45(3) doi: 10.1053/j.seminoncol.2018.03.001
9
Ganji Purnachandra Nagaraju, Bassel F. El‐Rayes. Cyclooxygenase‐2 in gastrointestinal malignancies. Cancer 2019; 125(8) doi: 10.1002/cncr.32010
10
Desmond P. Toomey, Ellen Manahan, Ciara McKeown, Annamarie Rogers, Helen McMillan, Michael Geary, Kevin C. Conlon, Joseph F. Murphy. Vascular Endothelial Growth Factor and not Cyclooxygenase 2 Promotes Endothelial Cell Viability in the Pancreatic Tumor Microenvironment. Pancreas 2010; 39(5) doi: 10.1097/MPA.0b013e3181c6575d
11
Kai-Wen Hsu, Rong-Hong Hsieh, Chew-Wun Wu, Chin-Wen Chi, Yan-Hwa Wu Lee, Min-Liang Kuo, Kou-Juey Wu, Tien-Shun Yeh, Richard K. Assoian. MBP-1 Suppresses Growth and Metastasis of Gastric Cancer Cells through COX-2. Molecular Biology of the Cell 2009; 20(24) doi: 10.1091/mbc.e09-05-0386
12
C.M. Richardson, D. Richardson, D.E.B. Swinson, W.A. Swain, G. Cox, K.J. O’Byrne. Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancer. Lung Cancer 2005; 48(1) doi: 10.1016/j.lungcan.2004.09.007
13
Chao Yan, Zheng-Gang Zhu, Ying-Yan Yu, Jun Ji, Yi Zhang, Yu-Bao Ji, Min Yan, Jun Chen, Bing-Ya Liu, Hao-Ran Yin, Yan-Zhen Lin. Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis. World Journal of Gastroenterology 2004; 10(6): 783-790 doi: 10.3748/wjg.v10.i6.783
14
Guanzhen Yu, Jiejun Wang, Ying Chen, Xi Wang, Jun Pan, Gang Li, Zhiliang Jia, Qiang Li, James C. Yao, Keping Xie. Overexpression of Phosphorylated Mammalian Target of Rapamycin Predicts Lymph Node Metastasis and Prognosis of Chinese Patients with Gastric Cancer. Clinical Cancer Research 2009; 15(5) doi: 10.1158/1078-0432.CCR-08-2138
15
Alexandra Thiel, Mira Heinonen, Johanna Rintahaka, Tuija Hallikainen, Annabrita Hemmes, Dan A. Dixon, Caj Haglund, Ari Ristimäki. Expression of Cyclooxygenase-2 Is Regulated by Glycogen Synthase Kinase-3β in Gastric Cancer Cells. Journal of Biological Chemistry 2006; 281(8) doi: 10.1074/jbc.M512722200
16
Sinan Sozen, Serhat Gurocak, Ozlem Erdem, Cenk Acar, Yakup Kordan, Gulen Akyol, Turgut Alkibay. Cyclooxygenase-2 expression: Does it have a probable role in tumorigenesis mechanisms of renal cell carcinoma?. International Urology and Nephrology 2008; 40(2) doi: 10.1007/s11255-007-9268-9
17
Fabiana G. Curea, Mohamed Hebbar, Silvia M. Ilie, Xenia E. Bacinschi, Oana G. Trifanescu, Inga Botnariuc, Rodica M. Anghel. Current Targeted Therapies in HER2-Positive Gastric Adenocarcinoma. Cancer Biotherapy and Radiopharmaceuticals 2017; 32(10) doi: 10.1089/cbr.2017.2249
18
Ya-nan Ji, Qin Wang, Yang Li, Zhi Wang. Prognostic value of vascular endothelial growth factor A expression in gastric cancer: a meta-analysis. Tumor Biology 2014; 35(3) doi: 10.1007/s13277-013-1371-1
19
Erin Jou, Lakshmi Rajdev. Current and emerging therapies in unresectable and recurrent gastric cancer. World Journal of Gastroenterology 2016; 22(20): 4812-4823 doi: 10.3748/wjg.v22.i20.4812
20
Jing Shi, Yi-Ping Qu, Peng Hou. Pathogenetic mechanisms in gastric cancer. World Journal of Gastroenterology 2014; 20(38): 13804-13819 doi: 10.3748/wjg.v20.i38.13804
21
Yanislav Kolev, Hiroyuki Uetake, Satoru Iida, Toshiaki Ishikawa, Tatsuyuki Kawano, Kenichi Sugihara. Prognostic Significance of VEGF Expression in Correlation With COX-2, Microvessel Density, and Clinicopathological Characteristics in Human Gastric Carcinoma. Annals of Surgical Oncology 2007; 14(10) doi: 10.1245/s10434-007-9484-7
22
H. Y. Seo, J. M. Park, K. H. Park, S. J. Kim, S. C. Oh, B. S. Kim, Y. H. Kim, J. S. Kim. Prognostic Significance of Serum Vascular Endothelial Growth Factor Per Platelet Count in Unresectable Advanced Gastric Cancer Patients. Japanese Journal of Clinical Oncology 2010; 40(12) doi: 10.1093/jjco/hyq111
23
Weida Gong, Liwei Wang, James C. Yao, Jaffer A. Ajani, Daoyan Wei, Kenneth D. Aldape, Keping Xie, Raymond Sawaya, Suyun Huang. Expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Expression of Vascular Endothelial Growth Factor in and Angiogenic Phenotype of Human Gastric Cancer. Clinical Cancer Research 2005; 11(4) doi: 10.1158/1078-0432.CCR-04-0487
24
Pamela New. Cyclooxygenase in the Treatment of Glioma: Its Complex Role in Signal Transduction. Cancer Control 2004; 11(3) doi: 10.1177/107327480401100303
25
Yun‐Chien Tseng, Yu‐Hui Tsai, Min‐Jen Tseng, Kai‐Wen Hsu, Min‐Chieh Yang, Kuo‐Hung Huang, Anna Fen‐Yau Li, Chin‐Wen Chi, Rong‐Hong Hsieh, Hung‐Hai Ku, Tien‐Shun Yeh. Notch2‐induced COX‐2 expression enhancing gastric cancer progression. Molecular Carcinogenesis 2012; 51(12) doi: 10.1002/mc.20865
26
Cynthia Farias Vieira de Melo, Carolina Oliveira Gigek, Juarez Nóbrega da Silva, Marilia de Arruda Cardoso Smith, Rubistenia Miranda de Araújo, Rommel Rodríguez Burbano, Eleonidas Moura Lima. Association of COX2 gene hypomethylation with intestinal type gastric cancer in samples of patients from northern Brazil. Tumor Biology 2014; 35(2) doi: 10.1007/s13277-013-1148-6
27
Alexandra Thiel, Johanna Mrena, Ari Ristimäki. Cyclooxygenase-2 and Gastric Cancer. Cancer and Metastasis Reviews 2011; 30(3-4) doi: 10.1007/s10555-011-9312-1
28
Xiangyang Zeng, Shuijing Yi. Cyclooxygenase Inhibitors in Epithelial Ovarian Cancer Treatment. International Journal of Gynecological Cancer 2018; 28(6) doi: 10.1097/IGC.0000000000001269
29
Anna Mahkonen, Heli Putaala, Harri Mustonen, Nina Rautonen, Pauli Puolakkainen. Lactobacillus acidophilus74-2 and Butyrate Induce Cyclooxygenase (COX)-1 Expression in Gastric Cancer Cells. Immunopharmacology and Immunotoxicology 2008; 30(3) doi: 10.1080/08923970802135229
30
Hiroyuki Mutoh, Miho Sashikawa, Hirotsugu Sakamoto, Tomoko Tateno. Cyclooxygenase 2 in Gastric Carcinoma Is Expressed in Doublecortin- and CaM Kinase-Like-1-Positive Tuft Cells. Gut and Liver 2014; 8(5) doi: 10.5009/gnl13237
31
Weiying Li, Hui Wang, Baitang Lai, Xuehui Yang, Chunyan Zhang. The effects of interfering in COX-2 gene expression on malignant proliferation of the human lung adenocarcinoma A2 cell in vitro. The Chinese-German Journal of Clinical Oncology 2009; 8(9) doi: 10.1007/s10330-009-0137-0
32
Nesreen H. Hafez, Neveen S. Tahoun. Expression of cyclooxygenase 2 and vascular endothelial growth factor in gastric carcinoma: Relationship with clinicopathological parameters. Journal of the Egyptian National Cancer Institute 2016; 28(3) doi: 10.1016/j.jnci.2016.05.005
33
Hongryull Pyo, Yong Bae Kim, Nam Hoon Cho, Chang Ok Suh, Tchan Kyu Park, Yeon Sook Yun, Gwi Eon Kim. Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy. International Journal of Radiation Oncology*Biology*Physics 2005; 62(3) doi: 10.1016/j.ijrobp.2004.10.044
34
Daniele Santini, Bruno Vincenzi, Giuseppe Tonini, Susanna Scarpa, Fortunata Vasaturo, Carolina Malacrino, Fabio Vecchio, Domenico Borzomati, Sergio Valeri, Roberto Coppola, Paolo Magistrelli, Gennaro Nuzzo, Aurelio Picciocchi. Cyclooxygenase-2 Overexpression Is Associated with a Poor Outcome in Resected Ampullary Cancer Patients. Clinical Cancer Research 2005; 11(10) doi: 10.1158/1078-0432.CCR-04-2136
35
Yun Shao, Kun Sun, Wei Xu, Xiao-Lin Li, Hong Shen, Wei-Hao Sun. <italic>Helicobacter pylori</italic> infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis. World Journal of Gastroenterology 2014; 20(36): 12860-12873 doi: 10.3748/wjg.v20.i36.12860
36
Tien-Shun Yeh, Chew-Wun Wu, Kai-Wen Hsu, Wan-Jung Liao, Min-Chieh Yang, Anna Fen-Yau Li, An-Ming Wang, Min-Liang Kuo, Chin-Wen Chi. The Activated Notch1 Signal Pathway Is Associated with Gastric Cancer Progression through Cyclooxygenase-2. Cancer Research 2009; 69(12) doi: 10.1158/0008-5472.CAN-08-4021
37
Zhen Wang, Jun-qiang Chen, Jin-lu Liu. COX-2 Inhibitors and Gastric Cancer. Gastroenterology Research and Practice 2014; 2014 doi: 10.1155/2014/132320
38
Frederico Theobaldo Ramos Rocha, Laercio Gomes Lourenço, Mário Jorge Jucá, Valéria Costa, Antenor Teixeira Leal. Chemoprevention by celecoxib in reflux-induced gastric adenocarcinoma in Wistar rats that underwent gastrojejunostomy. Acta Cirurgica Brasileira 2009; 24(3) doi: 10.1590/S0102-86502009000300005
39
Ling Peng, Ping Zhan, Yun Zhou, Weijia Fang, Peng Zhao, Yulong Zheng, Nong Xu. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis. Molecular Biology Reports 2012; 39(10) doi: 10.1007/s11033-012-1812-8
40
Jen-Hao Chen, Chew-Wun Wu, Hwa-Li Kao, Hwey-May Chang, Anna F-Y. Li, Tsung-Yun Liu, Chin-Wen Chi. Effects of COX-2 inhibitor on growth of human gastric cancer cells and its relation to hepatocyte growth factor. Cancer Letters 2006; 239(2) doi: 10.1016/j.canlet.2005.08.026
41
Zhangwei Xu, Hai Shi, Qiao Mei, Yuxian Shen, Jianming Xu. Effects of Macrophage Metalloelastase on the Basic Fibroblast Growth Factor Expression and Tumor Angiogenesis in Murine Colon Cancer. Digestive Diseases and Sciences 2012; 57(1) doi: 10.1007/s10620-011-1838-0
42
Johanna Mrena, Jan-Patrik Wiksten, Alexandra Thiel, Arto Kokkola, Leena Pohjola, Johan Lundin, Stig Nordling, Ari Ristimäki, Caj Haglund. Cyclooxygenase-2 Is an Independent Prognostic Factor in Gastric Cancer and Its Expression Is Regulated by the Messenger RNA Stability Factor HuR. Clinical Cancer Research 2005; 11(20) doi: 10.1158/1078-0432.CCR-05-0764
43
Qinzhong Chen, Nobuo Shinohara, Takashige Abe, Takafumi Watanabe, Katsuya Nonomura, Tomohiko Koyanagi. Significance of COX‐2 expression in human renal cell carcinoma cell lines. International Journal of Cancer 2004; 108(6) doi: 10.1002/ijc.11646
44
MINGSHENG HUANG, LONG WANG, JUNWEI CHEN, MINGJUN BAI, CHUREN ZHOU, SUJUAN LIU, QU LIN. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery. International Journal of Oncology 2016; 48(5) doi: 10.3892/ijo.2016.3421
45
Malin Sund, Michael Zeisberg, Raghu Kalluri. Endogenous Stimulators and Inhibitors of Angiogenesis in Gastrointestinal Cancers: Basic Science to Clinical Application. Gastroenterology 2005; 129(6) doi: 10.1053/j.gastro.2005.06.023
46
E.A. Griffiths, S.A. Pritchard, I.M. Welch, P.M. Price, C.M. West. Is the hypoxia-inducible factor pathway important in gastric cancer?. European Journal of Cancer 2005; 41(18) doi: 10.1016/j.ejca.2005.09.008
47
J Mrena, J-P Wiksten, S Nordling, A Kokkola, A Ristimäki, C Haglund. MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer. Journal of Clinical Pathology 2006; 59(6) doi: 10.1136/jcp.2005.033761
48
D. A. Heller, C. A. Clifford, M. H. Goldschmidt, D. E. Holt, F. S. Shofer, A. Smith, K. U. Sorenmo. Cyclooxygenase-2 Expression is Associated with Histologic Tumor Type in Canine Mammary Carcinoma. Veterinary Pathology 2005; 42(6) doi: 10.1354/vp.42-6-776
49
Yu Yang, Jiang Zhu, Hongfeng Gou, Dan Cao, Ming Jiang, Mei Hou. Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC). Medical Oncology 2011; 28(3) doi: 10.1007/s12032-010-9519-y
50
M. S. Al-Moundhri, I. Al-Hadabi, K. Al-Mawaly, S. Kumar, F. A. R. Al-Lawati, G. Bhatnager, S. Kuruvila, A. Al-Hamdani, S. M. El-Sayed, B. Al-Bahrani. Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer. Medical Oncology 2012; 29(3) doi: 10.1007/s12032-011-0098-3
51
Xiao-Guang Lu, Li-Bin Zhan, Bing-An Feng, Ming-Yang Qu, Li-Hua Yu, Ji-Hong Xie. Inhibition of growth and metastasis of human gastric cancer implanted in nude mice by <italic>d</italic>-limonene. World Journal of Gastroenterology 2004; 10(14): 2140-2144 doi: 10.3748/wjg.v10.i14.2140
52
Matthew H Kulke, Robert D Odze, James D Mueller, Helen Wang, Mark Redston, Monica M Bertagnolli. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer. The Journal of Thoracic and Cardiovascular Surgery 2004; 127(6) doi: 10.1016/j.jtcvs.2003.12.034
53
Labile Togba Soumaoro, Hiroyuki Uetake, Tetsuro Higuchi, Yoko Takagi, Masayuki Enomoto, Kenichi Sugihara. Cyclooxygenase-2 Expression. Clinical Cancer Research 2004; 10(24) doi: 10.1158/1078-0432.CCR-04-0653
54
A Juuti, J Louhimo, S Nordling, A Ristimäki, C Haglund. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer. Journal of Clinical Pathology 2006; 59(4) doi: 10.1136/jcp.2005.026831
55
Wolfgang Eberhardt, Anke Doller, El-Sayed Akool, Josef Pfeilschifter. Modulation of mRNA stability as a novel therapeutic approach. Pharmacology & Therapeutics 2007; 114(1) doi: 10.1016/j.pharmthera.2007.01.002
56
Weiying Li, Hui Wang, Baitang Lai, Xuehui Yang, Chunyan Zhang. The effects of the same target on malignant proliferation of human lung cancer cells with different expression levels of COX-2 protein. The Chinese-German Journal of Clinical Oncology 2010; 9(3) doi: 10.1007/s10330-009-0144-1
57
Rutvi Agrawal, Priyanka Jurel, Akash Garg, Bhupendra G. Prajapati, Sumel Ashique. Advances in Gastric Cancer Management: Signaling Pathways, Emerging Diagnostic and Therapeutic Strategies. Cancer Biotherapy and Radiopharmaceuticals 2026; 41(5) doi: 10.1177/10849785251408598
58
WENWEN SUI, YUEYING ZHANG, ZHAOPENG WANG, ZHAOXIA WANG, QING JIA, LICUN WU, WEIDONG ZHANG. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H22 murine hepatocarcinoma model. Oncology Reports 2014; 31(5) doi: 10.3892/or.2014.3093
59
Don Benjamin, Christoph Moroni. mRNA stability and cancer: an emerging link?. Expert Opinion on Biological Therapy 2007; 7(10) doi: 10.1517/14712598.7.10.1515
60
Masanobu Oshima, Hiroko Oshima, Makoto Mark Taketo. The Biology of Gastric Cancers. 2009;  doi: 10.1007/978-0-387-69182-4_20
61
Min Li, Shu-Ying Qi, Yong Wang, Shu-Xian Feng, Bang-Zhi Zhang, Rui Wang. Expression and clinical significance of vascular endothelial growth factor, cyclooxygenase-2, and Bcl-2 in borderline ovarian tumors. Archives of Gynecology and Obstetrics 2005; 272(1) doi: 10.1007/s00404-004-0708-9
62
D.P. Toomey, J.F. Murphy, K.C. Conlon. COX-2, VEGF and tumour angiogenesis. The Surgeon 2009; 7(3) doi: 10.1016/S1479-666X(09)80042-5
63
T. Wakatsuki, T. Mashima, N. Miyazaki, H. Osumi, S. Fukuoka, A. Ooki, K. Shimozaki, M. Ogura, K. Yoshino, S. Udagawa, E. Shinozaki, K. Chin, N. Ishida, H. Seimiya, K. Yamaguchi. BevRam-GC01 study protocol: a phase I trial of bevacizumab plus ramucirumab and paclitaxel in advanced gastric cancer. ESMO Gastrointestinal Oncology 2026; 11 doi: 10.1016/j.esmogo.2025.100299
64
Noem&iacute; Eir&oacute;, Francisco J Vizoso. Inflammation and cancer. World Journal of Gastrointestinal Surgery 2012; 4(3): 62-72 doi: 10.4240/wjgs.v4.i3.62
65
Bharat B Aggarwal, Prashasnika Gehlot. Inflammation and cancer: how friendly is the relationship for cancer patients?. Current Opinion in Pharmacology 2009; 9(4) doi: 10.1016/j.coph.2009.06.020
66
Sang Hyuk Seo, Mi Seon Kang, Kwang Hee Kim, Min Sung An, Tae Kwun Ha, Ki Beom Bae, Min Kyung Oh, Chang Soo Choi, Sang Hoon Oh, Young Kil Choi. Correlation of 15-prostagladin dehydrogenase expression with clinicopathological factors and survival rate in gastric adenocarcinoma. International Journal of Surgery 2015; 13 doi: 10.1016/j.ijsu.2014.10.009
67
Jian Song, Hong Su, Yang-yang Zhou, Liang-liang Guo. Cyclooxygenase-2 Expression Is Associated with Poor Overall Survival of Patients with Gastric Cancer: A Meta-Analysis. Digestive Diseases and Sciences 2014; 59(2) doi: 10.1007/s10620-013-2917-1
68
Rui Liu, Kang-Ping Xu, Gui-Shan Tan. Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed. European Journal of Pharmacology 2015; 769 doi: 10.1016/j.ejphar.2015.11.007
69
GUANGBING WEI, YUANHONG CHANG, JIANBAO ZHENG, SAI HE, NANZHENG CHEN, XIAOLONG WANG, XUEJUN SUN. Notch1 silencing inhibits proliferation and invasion in SGC-7901 gastric cancer cells. Molecular Medicine Reports 2014; 9(4) doi: 10.3892/mmr.2014.1920
70
Jannis Kountouras, Christos Zavos, Dimitrios Chatzopoulos. Apoptotic and anti-angiogenic strategies in liver and gastrointestinal malignancies. Journal of Surgical Oncology 2005; 90(4) doi: 10.1002/jso.20254
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.